Skip to content

Free cash flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$816M+126%
Danaher logo
DanaherDHR
$1.09B+2.9%
Agilent Technologies logo
Agilent TechnologiesA
$201M+87.9%
Illumina logo
IlluminaILMN
TEC
Bio-TechneTECH
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%

Valuation

See full
Market cap$5.45B+24.4%
Enterprise value$5.44B+30.4%
P/S13.3×+0.7×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Calculated from Twist Bioscience Corporation’s reported figures.

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's free cash flow?
Twist Bioscience Corporation (TWST) reported free cash flow of -$25.45M in Q1 2026.
How has Twist Bioscience Corporation's free cash flow changed year-over-year?
Twist Bioscience Corporation's free cash flow decreased by 48.5% year-over-year, from -$17.13M to -$25.45M.
What is the long-term trend for Twist Bioscience Corporation's free cash flow?
Over 4 years (2021 to 2025), Twist Bioscience Corporation's free cash flow has grown at a -14.2% compound annual growth rate (CAGR), from -$139.31M to -$75.63M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.